Am J Transplant, Volume 18, Suppl 3 Archives - Page 3 of 211 - ATC Abstracts

2018 American Transplant Congress
Prevalence, Risk Factors and Impact of BK Viremia on Kidney Transplantation: Single Center Experience
W. Hassan, A. El-Husseini, B. Suleiman, K. Wang, M. Yaseen, A. Maibam, A. Karim, A. Hines, A. Castellanos, V. Cornea, X. Mei, R. Gedaly, T. Waid.
Nephrology, University of Kentucky, Lexington, KY.
Introduction: BK viremia (BKV) is an emerging problem in renal transplantation. The risk factors and the impact of BKV on renal allograft and patient survival…
2018 American Transplant Congress
Side Effect Profile of Everolimus in Liver Transplant Patients
F. Kumssa, O. Sadiq, M. Alimirah, R. Kaur, A. Patel, S-.M. Jafri.
Henry Ford Hospital, Detroit.
IntroductionUse of calcineurin inhibitors has been the mainstay of antirejection medications after liver transplant (LT). However, renal toxicity from these drugs remains troublesome. By comparison,…
2018 American Transplant Congress
The Impact of a Tobacco Prohibition Policy Compared to a Restrictive Policy on Liver Transplant Candidate Outcomes
A. Likhitsup,¹ A. Hassan,¹ J. Mellinger,¹ F. Askari,¹ G. Winder,² P. Sharma,¹ N. Saeed,³ C. Sonnenday,⁴ R. Fontana.¹
¹Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI; ²Department of Psychiatry, University of Michigan, Ann Arbor, MI; ³Department of Internal Medicine, Beaumont Hospital, Dearborn, MI; ⁴Department of Surgery, University of Michigan, Ann Arbor, MI.
Introduction: Substance use disorders (SUD) are common in liver transplant (LT) candidates. Poorer postLT outcomes in tobacco users have led programs to prohibit tobacco use…
2018 American Transplant Congress
Impact of Early Corticosteroid Treatment in Patients with Indeterminate Acute Severe Hepatitis
E. Mohr,¹ R. Sucher,² T. Müller,³ T. Kaiser,⁴ T. Berg.¹
¹Hepatology, University Clinic Leipzig, Leipzig, Germany; ²Transplant Surgery, University Clinic Leipzig, Leipzig, Germany; ³Hepatology, Charite, Berliin, Germany; ⁴Laboratory Diagnostics, University Clinic Leipzig, Leipzig, Germany.
Background and Aims: Discrimination of acute severe autoimmune hepatitis AIH and drug induced liver injury in patients with indeterminate acute severe Hepatitis is challenging. Early…
2018 American Transplant Congress
High Body Mass Index in Organ Donor is Significantly Correlated to Low PaO₂/FiO₂ Ratio in SRTR Database
T. Okamoto,¹ L. Thuita,¹ H. Niikawa,¹ K. Ayyat,¹ Y. Itoda,¹ M. Valpour,² E. Blackstone,¹ K. McCurry.¹
¹Thoracic and Cardiovascular Surgery, Cleveland Clinic, Cleveland; ²Respiratory Medicine, Cleveland Clinic, Cleveland.
Background:Atelectasis is a major cause of hypoxemia in organ donors. However, the risk factors of hypoxemia unknown. Our previous study suggested that donors with high…
2018 American Transplant Congress
Modification of Macrophage Phenotype by the Magnetic Field
M. Kloc,¹ W. Chen,¹ J. Kubiak,^2,3 X. Li,¹ R. Ghobrial,¹ J. Wosik.⁴
¹Houston Methodist Research Institute, Houston, TX; ²WIHE, Warsaw, Poland; ³University of Rennes, Rennes, France; ⁴University of Houston, Houston.
Objective. Macrophages play a crucial role in health, disease and chronic rejection of transplanted organs. Chronic rejection of transplanted organs remains unresolved issue in organ…
2018 American Transplant Congress
Analyzing Transplant Medication Myths
R. Krislock, J. Brandenberger, P. Stracener, A. Weiss, K. Wipperling, C. Kuhr.
Division of Transplant, Virginia Mason Medical Center, Seattle, WA.
Patients may misconstrue the amount of medications required for transplantation, expecting to take “handfuls” of medications for life. This study aims to determine the change…
2018 American Transplant Congress
HIV-Positive Donors to HIV-Positive Transplant Recipients: The Italian Experience
P. Grossi,¹ D. Dalla Gasperina,¹ A. Petrolo,¹ D. Lombardi,¹ M. Balsamo,¹ M. Moioli,² G. Travi,² M. Merli,² F. Ferla,² M. Tozzi,¹ L. De Carlis,² G. Carcano,¹ M. Puoti,² A. Nanni Costa.³
¹Medicine and Surgery, University of Insubria-ASST Sette Laghi, Varese, Italy; ²ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy; ³Centro Nazionale Trapianti-ISS, Roma, Italy.
In order to expand the availability of organs for HIV-positive patients, successful transplantation of kidneys and livers from HIV-positive donors into selected HIV-positive recipients was…
2018 American Transplant Congress
Safety and Tolerability of Therapy for Latent Tuberculosis Infection: A 16-Year Review
Y. AlJishi, M. Bosaeed, S. Husain, C. Rotstein, A. Humar, D. Kumar.
Transplant Infectious Diseases, UHN, Toronto, ON, Canada.
Introduction:Screening and therapy of latent tuberculosis infection (LTBI) is recommended in transplant candidates. However, data on therapy of LTBI with fluoroquinolones are limited. We aimed…
2018 American Transplant Congress
Strongyloides Pre-Transplant Screening in Solid Organ Transplantation (SOT): Single Center Analysis
M. Al-Obaidi,¹ K. Vigil,¹ R. Hasbun,¹ A. De Golovine,² V. Machicao,³ L. Ostrosky,¹ S. Bynon,⁴ M. Nigo.¹
¹Division of Infectious Diseases, UT McGovern Medical School, Houston; ²Division of Renal Disease and Hypertension, UT McGovern Medical School, Houston; ³Division of Gastroenterology, Hepatology and Nutrition, UT McGovern Medical School, Houston; ⁴Division of Immunology and Organ Transplantation, UT McGovern Medical School, Houston.
Background: Strongyloides stercoralis infects about 100 million persons worldwide. In SOT, the optimal pre-transplant (Tsp) screening method (universal versus targeted) is yet to be determined.…